Neuro

Research from anesthesiology, pain and critical care journals, sourced from PubMed.

Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.

AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.

Last successful paper check: 16 Nov 2026 17:18 UTC. 0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
Article J Clin Anesth Published 14 Nov 2026
Perioperative management of patients with recent concussion undergoing noncardiac extracranial surgery: A modified Delphi consensus study.
AI-generated abstract summary · verify against the original paper
  • A two-round modified Delphi consensus study of 35 experts, 33 of them anesthesiologists from 17 countries, addressed adults with recent concussion having noncardiac extracranial surgery.
  • The panel rated statements on a five-point Likert scale, with consensus defined a priori as at least 75% agreement and strong consensus as at least 85%.
  • Of 16 Round 2 statements, 13 reached consensus, including unanimous agreement on preoperative screening and avoiding hypoxemia, hypotension, and marked hypertension, and strong consensus (97%) for generally deferring elective surgery until symptoms resolve.
  • Consensus was not reached for regional or monitored anesthesia care over general anesthesia (74%), EEG-guided depth monitoring (73%), or cautious long-acting neuraxial opioid use (69%); the authors describe the output as an expert-informed framework, not an evidence-based guideline.
PubMed indexed 14 Nov 2026 Imported 15 Nov 2026 Elganga M et al. Publisher NeuroPerioperative medicine
Meta-analysis Pain Med Published 13 Nov 2026
Perioperative Pregabalin for Persistent Postsurgical Pain After Lumbar Spine Surgery In Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
AI-generated abstract summary · verify against the original paper
  • Systematic review and meta-analysis of five placebo-controlled RCTs (335 participants) testing perioperative pregabalin in adults undergoing elective lumbar spine surgery.
  • Pregabalin was compared with placebo, with the primary outcome being pain intensity at 3 months, pooled across four trials (275 participants).
  • Pregabalin did not reduce 3-month pain intensity (SMD 0.03, 95% CI -0.41 to 0.47; I² 69%; low certainty).
  • Functional disability was lower with pregabalin (SMD -0.51, 95% CI -0.86 to -0.16), but the differences fell below minimal important change thresholds, with very low certainty.
PubMed indexed 13 Nov 2026 Imported 13 Nov 2026 Correia DG et al. Publisher Chronic painNeuroPerioperative medicine
Article Anesthesiology Published 13 Nov 2026
Childhood Exposure to General Anesthesia for Surgery: Identification of a Subtle Postoperative Cognitive Phenotype.
AI-generated abstract summary · verify against the original paper
  • Ambidirectional cohort of 77 children aged 9-11, with or without prior surgical general anesthesia exposure, tested on a cognitive battery.
  • Eight measures covered inhibitory control, cognitive flexibility, working memory, and visuo-spatial attention, analyzed with mixed-effects and exploratory latent profile models.
  • No overall exposure effect on executive function (χ²(1)=.01, p=.92), but exposure was linked to lower odds of the Efficient profile (OR 0.71, 95% CI [0.705, 0.710], p<.001).
  • Exposed children showed higher global-local precedence (estimate 0.53, 95% CI [0.04, 1.01], p=.036), which the authors describe as a possible post-operative phenotype.
PubMed indexed 22 Oct 2026 Imported 9 Nov 2026 Salaün JP et al. Publisher NeuroPediatric
Meta-analysis Crit Care Med Published 12 Nov 2026
New-Onset Atrial Fibrillation in Critically Ill Patients: A Systematic Review of In-Hospital and Post-Discharge Outcomes.
AI-generated abstract summary · verify against the original paper
  • A Bayesian systematic review and meta-analysis of 54 studies, including 367,896 critically ill adults, examined new-onset atrial fibrillation in general ICUs and high-dependency units.
  • It compared post-discharge systemic thromboembolism in patients with and without new-onset atrial fibrillation, with follow-up ranging from 1.5 months to 5 years.
  • Pooled NOAF incidence was 10.6% (95% CrI 8.6-12.9%), and post-discharge thromboembolism risk was 7.1% (95% CrI 4.5-11.0%). Relative risk was 1.94 (95% CrI 1.23-3.29) across six studies, rising to 2.01 with adjustment.
  • Anticoagulation use was low, at 32.9% in-hospital and 35.9% post-discharge, and 23.9% of patients with NOAF were later diagnosed with atrial fibrillation.
PubMed indexed 12 Nov 2026 Imported 13 Nov 2026 Tan SWZ et al. Publisher Critical careNeuro
RCT Crit Care Med Published 11 Nov 2026
The Effect of Guanfacine on Delirium in Surgical and Trauma ICU Patients: A Pilot Randomized Clinical Trial.
AI-generated abstract summary · verify against the original paper
  • Single-center, randomized, double-blind, placebo-controlled pilot trial of 100 critically ill adults with CAM-ICU-confirmed delirium in surgical and trauma ICUs.
  • Patients received 2 mg guanfacine or matching placebo nightly for up to 14 days, or until ICU discharge or delirium resolution.
  • Median delirium and coma-free days were 2 (IQR 0-6) with guanfacine versus 1 (IQR 0-4) with placebo (p = 0.02) in unadjusted analyses, but not significant after adjustment.
  • Feasibility targets were mostly met, with 100% adherence, retention, and data completeness, though COVID-19 limited recruitment to 0.9 patients/week; authors judge the signal worth a multicenter trial.
PubMed indexed 11 Nov 2026 Imported 12 Nov 2026 Barker AB et al. Publisher Critical careNeuro
Article Crit Care Med Published 11 Nov 2026
Composite Endpoints in Critical Care Delirium Trials.
AI-generated abstract summary · verify against the original paper
  • This methods paper uses data from the MENDS trial to examine composite endpoints for critical care delirium trials.
  • It evaluates two existing composites: delirium- and coma-free days, and a ranked endpoint that treats death as worst and orders delirium- and coma-free days among survivors.
  • The authors describe how to define treatment effects on each composite, assess their clinical interpretability, and visualize how effects accumulate over follow-up.
  • They provide practical recommendations for composite endpoints that could extend to other randomized trials using similar endpoints.
PubMed indexed 11 Nov 2026 Imported 12 Nov 2026 Smith BB et al. Publisher Critical careNeuro
Article Crit Care Med Published 11 Nov 2026
Circulating Cell-Free Mitochondrial DNA, Delirium, and Long-Term Cognitive Impairment in Critically Ill Adults With Sepsis: A Prospective Cohort Study.
AI-generated abstract summary · verify against the original paper
  • Multicenter prospective cohort of 480 adults with sepsis plus shock and/or acute respiratory failure, enrolled in medical and surgical ICUs in Nashville, TN.
  • Plasma ccf-mtDNA was measured on study days 1, 3, and 5 and related to delirium and coma; no intervention was given.
  • Higher ccf-mtDNA was associated with lower odds of delirium (OR 0.93, 95% CI 0.86-0.99; p = 0.048), but not with coma or 3- or 12-month cognition.
  • Mortality association was marginal (HR 1.09, 95% CI 0.99-1.20; p = 0.08); the authors urge cautious interpretation until the finding is replicated.
PubMed indexed 11 Nov 2026 Imported 12 Nov 2026 Onyemekwu CA et al. Publisher Critical careNeuro
Review Br J Anaesth Published 9 Nov 2026
Chronic preoperative benzodiazepine use and perioperative outcomes: a scoping review.
AI-generated abstract summary · verify against the original paper
  • This scoping review of 130 studies, mostly observational cohorts (83.8%), mapped literature on chronic preoperative benzodiazepine use and perioperative outcomes.
  • Chronic use was defined inconsistently, ranging from 1 month to over 1 year before surgery, and duration was not systematically defined in 47.7% of studies.
  • Postoperative opioid use (40.8% of studies) and delirium or cognitive impairment (14.6%) were the most examined outcomes, with most reporting adverse associations.
  • The authors conclude chronic use is a clinically relevant but inconsistently defined exposure, and that causal inference is not possible without risk-of-bias assessment and prospective studies.
PubMed indexed 9 Nov 2026 Imported 10 Nov 2026 Nurse R et al. Publisher NeuroPerioperative medicine
Article Eur J Anaesthesiol Published 6 Nov 2026
Postoperative delirium and 1-year functional decline, institutionalization and mortality.
AI-generated abstract summary · verify against the original paper
  • In a prospective multicentre observational study of 2442 adult surgical patients at 43 Spanish hospitals, 1899 completed 1-year telephone follow-up.
  • The exposure was postoperative delirium within 48 hours, screened with CAM, CAM-ICU or the telephone-administered 4AT depending on setting.
  • Delirium was independently associated with a 4.60-point higher WHODAS 2.0 score at 1 year (95% CI 1.57 to 7.64, P = 0.003), and with institutionalisation (OR 2.5, 95% CI 1.07 to 5.84, P = 0.03).
  • Mortality was 16.7% versus 3.1% (P < 0.001), and the authors conclude that delirium is a key perioperative complication that supports prevention and structured long-term follow-up.
PubMed indexed 20 Oct 2026 Imported 9 Nov 2026 de la Varga-Martínez O et al. Publisher Neuro
Review Eur Heart J Published 6 Nov 2026
Delirium in cardiovascular medicine.
AI-generated abstract summary · verify against the original paper
  • This state-of-the-art review covers delirium epidemiology, mechanisms, diagnosis, prevention and treatment across cardiovascular medicine, drawing on interdisciplinary expert input.
  • It identifies risk factors such as advanced age, baseline cognitive impairment, cerebrovascular disease, longer operative times, complications and systemic inflammation.
  • Non-pharmacological multicomponent prevention is described as strongly supported, while preventive pharmacologic use remains controversial; dexmedetomidine is noted for ICU settings.
  • The authors conclude that systematic risk assessment and multimodal prevention should be standard care, with more high-quality studies needed for cardiovascular-specific guidelines.
PubMed indexed 19 Feb 2026 Imported 9 Nov 2026 Cekaj E et al. Publisher CardiacNeuroPerioperative medicine
Review World Neurosurg Published 3 Nov 2026
Beyond Weight Loss: A Scoping Review and Thematic Analysis of GLP-1 Receptor Agonists Across the Neurosurgical Landscape.
AI-generated abstract summary · verify against the original paper
  • Scoping review (PRISMA-ScR) of 48 included studies from 1,342 screened, mostly US-based and retrospective (43/48).
  • Included studies examined GLP-1 receptor agonist exposure in adults with spinal, intracranial, or cerebrovascular disease, grouped into three themes.
  • Spinal fusion studies repeatedly linked perioperative exposure to lower pseudarthrosis, though some reported more postoperative complications; IIH studies linked it to lower papilledema and shunt placement.
  • The authors judge benefit signals most consistent in spinal fusion and IIH, but adverse effects and database overlap limit causal inference, and they call for prospective trials.
PubMed indexed 3 Nov 2026 Imported 9 Nov 2026 Diamandi J et al. Publisher Neuro
Review Eur Geriatr Med Published 30 Oct 2026
Effects of perioperative dexmedetomidine on postoperative delirium in older surgical patients: an updated meta-analysis of randomized controlled trials.
AI-generated abstract summary · verify against the original paper
  • Meta-analysis of 22 RCTs including 4161 older surgical patients under general anesthesia, searched across PubMed, Embase and CENTRAL through July 2026.
  • Compared perioperative intravenous dexmedetomidine with control for prevention of postoperative delirium, the primary outcome.
  • Dexmedetomidine reduced postoperative delirium (RR 0.56, 95% CI 0.47 to 0.66; P<0.00001; I² 24%) and PONV (RR 0.79, 95% CI 0.62 to 0.99; P=0.04).
  • Dexmedetomidine was associated with more intraoperative and postoperative bradycardia and more intraoperative hypotension.
PubMed indexed 31 Oct 2026 Imported 9 Nov 2026 Shi CG et al. Publisher NeuroPerioperative medicinePharmacology
Review J Clin Anesth Published 30 Oct 2026
Processed electroencephalogram-guided anesthesia and its impact on postoperative delirium and perioperative efficiency: A systematic review and meta-analysis.
AI-generated abstract summary · verify against the original paper
  • Systematic review and meta-analysis of 87 RCTs enrolling 30,611 adults undergoing surgical, endoscopic, or dental procedures.
  • Compared pEEG-guided with non-pEEG-guided anesthesia on anesthetic drug use, postoperative delirium, and perioperative efficiency measures.
  • pEEG reduced propofol use (SMD -0.42) and volatile agent use (SMD -1.27), and postoperative delirium risk fell (RR 0.73, 95% CI 0.63 to 0.84).
  • Extubation, wake-up, orientation, and PACU stay were all shorter with pEEG, with BIS showing the most consistent benefit and substantial heterogeneity for several outcomes.
PubMed indexed 30 Oct 2026 Imported 9 Nov 2026 Hormis A et al. Publisher NeuroPerioperative medicine
RCT Br J Anaesth Published 29 Oct 2026
Effect of remimazolam versus propofol anaesthesia on postoperative delirium in neurovascular surgery: a randomised noninferiority trial.
AI-generated abstract summary · verify against the original paper
  • Single-centre, double-blind randomised noninferiority trial of 686 adults having elective neurovascular surgery, analysed as a modified intention-to-treat population.
  • Patients received remimazolam-based TIVA with flumazenil reversal at emergence or propofol-based TIVA, both with remifentanil.
  • Postoperative delirium within 5 days occurred in 12.8% (44/344) with remimazolam and 10.8% (37/342) with propofol; risk difference 1.97 percentage points (95% CI -2.85 to 6.80).
  • Remimazolam met the prespecified noninferiority criterion, and that group had less intraoperative hypotension below a MAP of 65 mm Hg and more operating-room extubation.
PubMed indexed 29 Oct 2026 Imported 9 Nov 2026 Kim J et al. Publisher NeuroPharmacology
Review Rev Esp Anestesiol Reanim (Engl Ed) Published 29 Oct 2026
Dexmedetomidine versus propofol for the prevention of postoperative delirium in older adults undergoing regional anaesthesia: A systematic review and meta-analysis.
AI-generated abstract summary · verify against the original paper
  • Systematic review and meta-analysis of five randomized trials, totaling 1613 adults aged 60 or older having surgery under regional anesthesia.
  • Compared intraoperative dexmedetomidine with propofol, with delirium assessed using CAM or CAM-ICU.
  • Delirium occurred in 7.7% of dexmedetomidine patients versus 16.7% with propofol (RR 0.48, 95% CI 0.36-0.64; P < .001), with low heterogeneity (I² = 13.4%).
  • The authors conclude dexmedetomidine is associated with less postoperative delirium, and they rated the certainty of evidence as moderate by GRADE.
PubMed indexed 29 Oct 2026 Imported 9 Nov 2026 Estefó M et al. Publisher NeuroPharmacologyRegional
Meta-analysis Int J Spine Surg Published 29 Oct 2026
Do Preoperative Glucagon-Like Peptide-1 Receptor Agonists Influence Lumbar Fusion Outcomes? A Systematic Review and Meta-Analysis.
AI-generated abstract summary · verify against the original paper
  • Systematic review and meta-analysis of seven retrospective cohorts (28,525 patients) comparing lumbar fusion patients with and without preoperative GLP-1RA exposure.
  • Six of the seven studies used propensity score matching or another matching strategy to balance the comparison groups.
  • No significant association with reoperation or revision (OR 0.74, 95% CI 0.44-1.24; P = 0.25) or postoperative infection (OR 0.83, 95% CI 0.68-1.00; P = 0.05).
  • The authors found no signal of increased postoperative risk and called for prospective studies with standardized exposure definitions and perioperative management protocols.
PubMed indexed 17 Sep 2026 Imported 9 Nov 2026 Alves MLM et al. Publisher NeuroPerioperative medicine
Review Diagnostics (Basel) Published 27 Oct 2026
Postoperative Delirium Across the Perioperative Pathway: A Structured Narrative Review of Clinical Maturity and Implementation Priorities.
AI-generated abstract summary · verify against the original paper
  • This structured narrative review synthesizes adult postoperative delirium evidence across the perioperative pathway, searching major databases plus ESAIC and ASA resources and reference lists.
  • It classifies prevention and therapeutic strategies by clinical maturity, target population, and implementation readiness rather than by pooled effect size.
  • The authors report that no single anesthetic technique, processed-EEG target, blood-pressure threshold, cerebral oximetry strategy, or agent consistently prevents delirium across surgical populations.
  • Multicomponent non-pharmacological prevention has the most consistent support, dexmedetomidine appears context-dependent, and biomarkers and metabolic targets remain investigational.
PubMed indexed 14 Nov 2026 Imported 14 Nov 2026 Katona OB et al. Publisher NeuroPerioperative medicine
Review J Clin Anesth Published 25 Oct 2026
Preoperative cognitive training for preventing perioperative neurocognitive disorders: A systematic review and meta-analysis with trial sequential analysis and meta-regression of randomised controlled trials.
AI-generated abstract summary · verify against the original paper
  • Systematic review and meta-analysis of 13 RCTs including 1446 patients comparing preoperative cognitive training with usual care.
  • Primary outcomes were postoperative delirium, delayed neurocognitive recovery, and postoperative neurocognitive disorder.
  • Training was associated with lower postoperative delirium risk (RR 0.53, 95% CI 0.36-0.77, P=0.001), though certainty was rated low.
  • The delayed neurocognitive recovery reduction (RR 0.66, 95% CI 0.46-0.96) was not robust to sensitivity analyses, and traditional training may outperform digital training for delirium.
PubMed indexed 25 Oct 2026 Imported 9 Nov 2026 Gao Y et al. Publisher NeuroPerioperative medicine
Article Anesth Analg Published 22 Oct 2026
Association of Altered Anteriorization of Electroencephalographic Alpha Oscillation During Transition to Unconsciousness With Postoperative Delirium: A Prospective Observational Study.
AI-generated abstract summary · verify against the original paper
  • Prospective exploratory observational study of 83 elderly patients from one tertiary hospital under sevoflurane anesthesia with 19-channel EEG, after 17 excluded for artifacts.
  • Exposure was EEG alpha anteriorization and network efficiency across induction, maintenance, emergence, and PACU phases, compared between patients with and without postoperative delirium.
  • Just before loss of responsiveness, nondelirium patients showed frontal alpha power of 4.24 vs -0.88 dB (P = .007), whereas delirium patients showed minimal change.
  • During maintenance, the delirium group had longer averaged characteristic path lengths (4.49 ± 0.62 vs 3.57 ± 0.16, P = .026, FDR-corrected), suggesting reduced network efficiency.
PubMed indexed 23 Oct 2026 Imported 9 Nov 2026 Kim YS et al. Publisher Neuro
Review Front Pediatr Published 21 Oct 2026
Dose- and endpoint-dependent effects of perioperative esketamine in children: evidence from a targeted review.
AI-generated abstract summary · verify against the original paper
  • This mini review synthesizes a targeted search of pediatric esketamine studies covering analgesia, sedation, propofol injection pain, and emergence delirium or agitation.
  • Randomized trials and meta-analyses generally report fewer emergence delirium or agitation events after low intravenous esketamine doses, mostly during sevoflurane adenotonsillectomy.
  • Direct dose-comparison evidence in that setting shows increasing benefit up to 0.5 mg/kg intravenously, with no upper efficacy or safety boundary identified.
  • The authors conclude that 0.2-0.5 mg/kg IV was the best-studied range for emergence prevention, not a validated therapeutic window, and call for direct dose-timing trials.
PubMed indexed 5 Nov 2026 Yang Y et al. Publisher NeuroPediatricPerioperative medicinePharmacology
Article Spine J Published 21 Oct 2026
Outcomes after Posterior Cervical Spine Surgery: A Matched Cohort Analysis and Comparison of GLP-1 Receptor Agonist Use and Bariatric Surgery in Patients with Type 2 Diabetes.
AI-generated abstract summary · verify against the original paper
  • Retrospective PearlDiver Mariner database study of patients with type 2 diabetes on metformin who underwent posterior cervical surgery from 2010 to 2023, using propensity-score matching.
  • Preoperative GLP-1 receptor agonist users were compared with matched non-users and with patients who had prior bariatric surgery.
  • GLP-1 users had lower odds of perioperative pneumonitis (OR 0.57; 95% CI 0.43-0.75; p<0.001) and of 90-day revision surgery (OR 0.33; 95% CI 0.29-0.36; p<0.001).
  • Lower odds persisted for 2-year revision surgery and nutritional deficiency, and no significant differences were found versus the bariatric surgery cohort.
PubMed indexed 22 Oct 2026 Imported 9 Nov 2026 Rivera N et al. Publisher NeuroPerioperative medicine
Article Br J Anaesth Published 19 Oct 2026
Brain-derived tau in plasma and cerebrospinal fluid after surgery: a prospective cohort substudy.
AI-generated abstract summary · verify against the original paper
  • Prospective cohort substudy of adults undergoing hip or knee arthroplasty, measuring plasma and CSF brain-derived tau before neuraxial anaesthesia and up to 48 h after surgery.
  • Plasma brain-derived tau peaked at 4 h with a 254% rise (IQR 137-382%, P<0.001) and was still 31% above baseline at 48 h (6-75%, P<0.001).
  • CSF brain-derived tau was unchanged at 4 h but rose 51% by 48 h (21-82%, P=0.004), and plasma and CSF levels were inversely associated (β=-0.71, P<0.001).
  • The authors suggest the early plasma rise reflects redistribution of tau from the CNS rather than concomitant neuronal injury; higher plasma levels were also associated with worse cognition at 3 months.
PubMed indexed 19 Oct 2026 Imported 9 Nov 2026 Thorsson M et al. Publisher Neuro
Meta-analysis Anesth Analg Published 16 Oct 2026
Effects of Ketamine and Esketamine on Postoperative Delirium After General Anesthesia: A Meta-Analysis and Meta-Regression Analysis.
AI-generated abstract summary · verify against the original paper
  • Meta-analysis of 25 randomized controlled trials (3344 patients) comparing perioperative ketamine or esketamine with placebo or standard care for postoperative delirium.
  • Ketamine (9 trials) and esketamine (16 trials) were compared with control, with subgroup analyses by dose, regimen, surgery type and timing of assessment.
  • Both agents reduced postoperative delirium risk: ketamine RR 0.69 (95% CI 0.49-0.98, P = .04) and esketamine RR 0.58 (95% CI 0.36-0.95, P = .03).
  • Dizziness risk rose (RR 1.45, 95% CI 1.14-1.84), and trial sequential analysis found the evidence inconclusive, so the authors call for large multicenter RCTs.
PubMed indexed 16 Oct 2026 Imported 9 Nov 2026 Li S et al. Publisher NeuroPharmacology
Meta-analysis Crit Care Med Published 15 Oct 2026
Open Visiting Policy and Delirium in Adult Patients in ICUs: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
AI-generated abstract summary · verify against the original paper
  • Systematic review and meta-analysis of 13 randomized trials including 3,861 adult ICU patients, comparing open or flexible family visiting with restricted visiting.
  • Delirium was the primary outcome; secondary outcomes were invasive ventilation duration, ICU length of stay, hospital-acquired infections, and ICU mortality.
  • Open or flexible presence reduced delirium (RR 0.48; 95% CI 0.29-0.81; low certainty) and invasive ventilation duration (MD -0.36 d; 95% CI -0.46 to -0.26 d; low certainty).
  • No effect was seen on ICU length of stay, infections, or ICU mortality; the authors note low certainty of evidence and substantial heterogeneity.
PubMed indexed 15 Oct 2026 Imported 9 Nov 2026 Sella N et al. Publisher Critical careNeuro
Article J Clin Anesth Published 13 Oct 2026
Arterial-to-end-tidal carbon dioxide gradient as a risk marker for recorded 90-day mortality in intracranial neurosurgery: a retrospective INSPIRE cohort study of patients with early blood gas monitoring.
AI-generated abstract summary · verify against the original paper
  • Retrospective cohort of 1907 adults having a first intracranial operation in the INSPIRE database (2011-2020), with PaCO₂ drawn within 60 minutes and paired ETCO₂.
  • The exposure was the first-hour arterial-to-end-tidal CO₂ gradient, examined against database-recorded all-cause death within 90 days.
  • A larger gradient was associated with mortality, with an OR of 1.38 per 5 mmHg (95% CI 1.09-1.73) and 1.34 (95% CI 1.06-1.69) in the revised model with 92 events.
  • Adding the gradient barely changed optimism-corrected AUC (0.832 to 0.833) and did not improve the Brier score, and neither component was shown to predominate.
PubMed indexed 13 Oct 2026 Imported 9 Nov 2026 Li S et al. Publisher Neuro
RCT Anesth Analg Published 9 Oct 2026
Artificial Intelligence-Driven Clinical Decision Support for Postoperative Delirium Prevention: A Pragmatic Randomized Controlled Trial.
AI-generated abstract summary · verify against the original paper
  • Pragmatic randomized trial at Mount Sinai Hospital including 7294 surgical patients with preoperative cognitive impairment identified by NLP, MMSE scores, or diagnostic codes.
  • Patients were randomized to an AI-driven, non-interruptive EHR decision support tool aimed at anesthesia team adherence, or to routine perioperative care.
  • Only 1255 patients (17.2%) had documented delirium assessments; delirium occurred in 35.1% of intervention and 32.7% of control patients (P = .37).
  • Best practice adherence did not differ significantly between groups (all P > .05), and the authors call for further work on using these tools effectively.
PubMed indexed 9 Oct 2026 Imported 9 Nov 2026 Scharp D et al. Publisher Neuro
RCT Anesth Analg Published 7 Oct 2026
Effect of Deep Versus Moderate Neuromuscular Block on Chronic Postsurgical Pain After Lumbar Spine Surgery: A Randomized Clinical Trial.
AI-generated abstract summary · verify against the original paper
  • Randomized trial of 178 analyzed patients undergoing posterior lumbar interbody fusion, comparing deep and moderate neuromuscular blockade.
  • Deep neuromuscular blockade was compared with moderate blockade, with 3-month chronic postsurgical pain incidence as the primary outcome.
  • Chronic pain at 3 months was 19.1% with deep block vs 34.8% with moderate block (RR 0.6; 95% CI 0.3-0.9; P = .018), with no significant difference at 6 months (RR 0.8; 95% CI 0.4-1.5; P = .423).
  • Deep block was linked to lower CK, myoglobin and LDH on day 1 and better paraspinal muscle preservation on 6-month MRI; authors attribute benefit to less muscle injury.
PubMed indexed 8 Oct 2026 Imported 9 Nov 2026 Wang X et al. Publisher Neuro
Observational Reg Anesth Pain Med Published 5 Oct 2026
Objective, long-term mobility data in patients with chronic pain after lumbar spine surgery treated with spinal cord stimulation-a prospective, multicenter trial.
AI-generated abstract summary · verify against the original paper
  • Prospective multicenter trial of 50 enrolled patients with chronic back and/or leg pain after lumbar spine surgery, of whom 32 completed 12-month activity follow-up.
  • Baseline mobility was recorded with an accelerometer-equipped external stimulator, and permanent spinal cord stimulation followed if patients achieved at least 50% pain relief on trial.
  • Mobility episodes of at least 30 seconds were 34±27 min/24 hours at baseline versus 92±51 min in healthy controls (p=0.009), and rose significantly only by 12 months (p=0.045).
  • The increase was significant in leg-predominant pain (35±27 to 54±32 min, p=0.011) but not back-predominant pain, and mobility correlated with reduced disability (p=0.044) and leg pain (p=0.046).
PubMed indexed 10 Jul 2025 Imported 9 Nov 2026 Hallén T et al. Publisher Chronic painNeuroRegional
Article J Cardiothorac Vasc Anesth Published 2 Oct 2026
Association of Enteral Chloral Hydrate with Benzodiazepine Exposure and Delirium After Pediatric Cardiac Surgery: A Retrospective Before-and-After Cohort Study.
AI-generated abstract summary · verify against the original paper
  • Single-center retrospective before-and-after cohort of 86 children after congenital heart surgery with cardiopulmonary bypass, mechanically ventilated over 24 hours, in a tertiary pediatric cardiac ICU.
  • Compared an institutional sedation protocol before versus after adding enteral chloral hydrate as an adjunctive sedative.
  • Cumulative midazolam exposure was lower with chloral hydrate (10.2 vs 13.2 mg/kg, p = 0.010), and observed delirium was lower (14.6% vs 37.8%, p = 0.015).
  • Sedation quality, pain scores, withdrawal, ventilation duration, length of stay, and mortality did not differ significantly; the authors call for prospective multicenter confirmation.
PubMed indexed 23 Oct 2026 Imported 9 Nov 2026 Ozden O et al. Publisher CardiacNeuroPediatric
RCT Drug Des Devel Ther Published 2 Oct 2026
Intraoperative Dexmedetomidine and Postoperative Delirium After Head and Neck Cancer Surgery with Free-Flap Reconstruction: A Secondary Analysis of a Randomized Placebo-Controlled Trial.
AI-generated abstract summary · verify against the original paper
  • This delirium-focused secondary analysis of a single-centre, double-blind, placebo-controlled trial enrolled adults having head and neck cancer surgery with free-flap reconstruction.
  • Patients received intraoperative dexmedetomidine at 0.3 μg/kg/h until 1 hour before surgery ended, or comparable volumes of saline placebo.
  • Delirium over the first 5 postoperative days occurred in 14.9% (7/47) of dexmedetomidine patients versus 34.7% (17/49) of placebo patients (adjusted OR 0.31, 95% CI 0.10-0.92; p = 0.036).
  • Pain and early sleep were reported as improved with dexmedetomidine, and haemodynamic adverse events and postoperative complications did not differ significantly between groups.
PubMed indexed 7 Oct 2026 Imported 9 Nov 2026 Zhang SJ et al. Publisher NeuroPerioperative medicinePharmacology
Article Anesth Analg Published 23 Sep 2026
Intraoperative Ketamine and Chronic Opioid Use After Lumbar Spine Surgery in Patients With and Without Opioid-Use Disorder: A Retrospective Database Analysis.
AI-generated abstract summary · verify against the original paper
  • Propensity-matched retrospective cohort using TriNetX electronic health records of adults undergoing lumbar spine surgery from 2010 to 2024, with 53,639 opioid-naive and 2031 OUD patients analyzed.
  • Exposure was intraoperative ketamine, analyzed separately in opioid-naive patients and those with opioid-use disorder.
  • Ketamine was linked to more outpatient opioid prescribing in opioid-naive patients at 48 hours (RR 1.23, 95% CI 1.22-1.25) and 6 weeks (RR 1.14, 95% CI 1.10-1.18).
  • Adverse events and new OUD diagnoses were not reduced and were similar or higher with ketamine, so the authors found no detectable population-level opioid-sparing signal.
PubMed indexed 23 Sep 2026 Imported 9 Nov 2026 Desverreaux E et al. Publisher NeuroPharmacology
Article Pain Published 23 Sep 2026
Clinical and preclinical investigation of the mechanism promoting aura in post-traumatic headache and inhibition of pain-related behavior in mice by onabotulinumtoxinA.
AI-generated abstract summary · verify against the original paper
  • This study combined a human cohort of post-traumatic headache patients without prior aura with a mouse model of mild TBI, using electrophysiology, neuroimaging, and behavioral assays.
  • Mice received closed-head mTBI, and separately onabotulinumtoxinA was given subcutaneously to the scalp after injury, with optogenetically evoked CSD used to probe pain behavior.
  • In humans, 35 of 108 patients (32%) developed new aura within 60 days, and injured mice showed a 160% increase in CSD induction probability.
  • OnabotulinumtoxinA did not change CSD susceptibility but completely abolished optogenetic CSD-induced allodynia, which the authors suggest may help treat PTH with aura.
PubMed indexed 23 Sep 2026 Imported 9 Nov 2026 Bader C et al. Publisher Chronic painNeuro
Review Br J Anaesth Published 22 Sep 2026
The effect of near-infrared spectroscopy guided intraoperative care on neurocognitive and functional outcomes after cardiac surgery: a systematic review and meta-analysis of randomised controlled trials.
AI-generated abstract summary · verify against the original paper
  • Systematic review and meta-analysis of 17 RCTs (N=2288) comparing NIRS-guided with usual-care intraoperative management in adults undergoing on-pump cardiac surgery.
  • Outcomes assessed included postoperative cognitive decline, delirium, stroke, mortality and functional recovery.
  • NIRS guidance probably reduced early postoperative cognitive decline (RR 0.65, 95% CI 0.42-0.99; moderate certainty).
  • Effects on stroke, mortality and delirium were imprecise with low certainty, and no included trial measured validated quality of life or function.
PubMed indexed 14 Oct 2026 Imported 9 Nov 2026 Abdali T et al. Publisher CardiacNeuro
Observational J Clin Anesth Published 22 Sep 2026
The Co-TELE-SURGE study: A prospective cohort proof-of-concept study of perioperative cognitive trajectories in older adults undergoing noncardiac surgery.
AI-generated abstract summary · verify against the original paper
  • Prospective proof-of-concept cohort of 84 adults aged 65 or older awaiting elective noncardiac surgery, tested remotely with Cogstate from preoperatively to 12 months.
  • An interrupted time-series analysis compared cognitive trajectories before and after surgery, accounting for preoperative trends rather than a single baseline.
  • Surgery was associated with a small decline in psychomotor and attention level (p = 0.017), and postoperative trajectories improved versus preoperative in psychomotor (p = 0.008), attention (p = 0.002), and visual learning (p = 0.007).
  • After adjusting for confounders, only the postoperative level change in attention remained significant (p = 0.027), and the authors call the findings exploratory and in need of adequately powered confirmation.
PubMed indexed 25 Sep 2026 Imported 9 Nov 2026 Khaled M et al. Publisher NeuroPerioperative medicine
RCT JAMA Published 22 Sep 2026
Total Intravenous vs Volatile Inhalational Anesthesia for Major Noncardiac Surgery: A Randomized Clinical Trial.
AI-generated abstract summary · verify against the original paper
  • Pragmatic, open-label, multicenter randomized trial of 2508 adults aged 50 or older having elective major noncardiac surgery at 49 UK NHS hospitals.
  • Patients were randomized 1:1 to maintenance of general anesthesia with propofol TIVA or volatile inhalational agents, with other perioperative care left to clinician discretion.
  • Days alive and at home at 30 days were similar (22.5 vs 22.4 days; incidence rate ratio 1.00, 95% CI 0.99-1.02; adjusted P = .68).
  • TIVA was associated with lower reported thirst, hoarseness, and nausea/vomiting; major complications (12.4% overall) did not differ between groups.
PubMed indexed 12 Aug 2026 Imported 9 Nov 2026 Jhanji S et al. Publisher NeuroPerioperative medicinePharmacology
Article Crit Care Med Published 21 Sep 2026
Epilepsy After Antipsychotic Prescription in Survivors of Traumatic Brain Injury: A Population-Based Cohort Study.
AI-generated abstract summary · verify against the original paper
  • Retrospective population-based cohort of 1204 adults aged 66 or older in Ontario, Canada (2009-2021), who survived a first TBI admission and started a new antipsychotic within 30 days of discharge.
  • Compared new haloperidol or risperidone prescriptions against quetiapine for risk of new epilepsy diagnosis over up to 5 years, using inverse probability of treatment weighting with cause-specific Cox models.
  • Haloperidol was not associated with higher epilepsy risk (aHR 0.73; 95% CI 0.39-1.34), and risperidone was not either (aHR 0.94; 95% CI 0.65-1.36) compared with quetiapine.
  • Authors found no clear signal of differential epilepsy risk, but note high mortality limited comparability across groups, CIs were wide, and confirmatory studies are needed.
PubMed indexed 21 Sep 2026 Imported 9 Nov 2026 Ferraris A et al. Publisher Critical careNeuro
Article J Cardiothorac Vasc Anesth Published 17 Sep 2026
Correlation Between Respiratory Blood Flow Velocity Variation and Dynamic Preload Variables During Coronary Artery Bypass Surgery: A Pilot Observational Study.
AI-generated abstract summary · verify against the original paper
  • Prospective observational pilot study of 30 adults undergoing elective coronary artery bypass grafting at a single university hospital.
  • Modified passive leg raising was performed at three intraoperative time points, with pressure-based dynamic preload indices compared against echocardiographic flow velocity variations.
  • Stroke volume variation fell from 13% ± 4% to 10% ± 4% and pulse pressure variation from 10% ± 2% to 7% ± 3% (both p < 0.05); pressure- and flow-derived indices correlated weakly (r = 0.147-0.351).
  • Authors concluded that pressure-derived indices correlated only weakly with echocardiographic respiratory peak velocity variations, and the physiological meaning of these correlations remains uncertain since forward flow did not measurably increase.
PubMed indexed 22 Oct 2026 Imported 9 Nov 2026 Stephan AE et al. Publisher CardiacNeuro
Older